Advanced Enzyme Technologies Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Advanced Enzyme Technologies Limited generated cash of $1,413,690,000, which is more than the previous year. Cash used in financing activities reached the amount of -$507,060,000 last year. Net change in cash is therefore $173,310,000.
Cash Flow
| 2011 | 11.75M | -182.58M | 300.95M |
|---|---|---|---|
| 2012 | 905.46M | -1.99B | 999.41M |
| 2016 | 977.51M | -90.84M | -616.09M |
| 2018 | 1.15B | -781.88M | -20.66M |
| 2020 | 1.40B | -444.98M | -385.54M |
| 2021 | 1.62B | -260.33M | -263.1M |
| 2023 | 1.40B | -2.98B | -257.98M |
| 2024 | 1.41B | -646.49M | -507.06M |
ADVENZYMES.NS Cash Flow Statement (2011 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 964.2M | 2.67B | 826.64M | 230.62M | 75.05M | 42.54M | 148.80M | 18.67M |
Operating activities | ||||||||
Net income | 1.33B | 1.40B | 2.10B | 1.79B | 1.38B | 1.18B | 337.54M | 166.72M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 352.42M | 350.29M | 284.12M | 257.78M | 182.98M | 87.19M | 54.97M | 49.84M |
Stock-based compensation expense | 30.31M | 0 | 3.81M | 8.88M | 24.5M | 0 | 0 | 0 |
| Deferred income tax benefit | 30.31M | 0 | 3.81M | 8.88M | 24.5M | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 9.26M | -99.54M | -72.24M | -139.05M | 56.01M | -51.73M | 0 | 0 |
Inventories | -238.34M | 7.55M | -81.8M | -5.2M | -37.95M | -78.6M | -112.08M | 82.77M |
Accounts payable | -39.41M | 60.28M | 14.73M | -6.79M | -26.25M | 6.86M | 0 | 0 |
Cash generated by operating activities | 1.41B | 1.40B | 1.62B | 1.40B | 1.15B | 977.51M | 905.46M | 11.75M |
Investing activities | ||||||||
Purchases Of Investments | -304.3M | -2.68B | -58.88M | -10.24M | -120K | -900K | 0 | 0 |
Investments In Property Plant And Equipment | -423.13M | -381.81M | -195.8M | -506.51M | -109.53M | -98.22M | -2.00B | -251.42M |
Acquisitions Net | 0 | -65.45M | -16.26M | 2.04M | -675.97M | 310K | 0 | 0 |
Cash generated by investing activities | -646.49M | -2.98B | -260.33M | -444.98M | -781.88M | -90.84M | -1.99B | -182.58M |
Financing activities | ||||||||
Common Stock Issued | 0 | 1.42M | 3M | 1.77M | 0 | 0 | 0 | 0 |
Payments for dividends | -567.12M | -125.42M | -79.81M | -105.24M | -76M | -26.55M | -12.09M | -786.85K |
Repurchases of common stock | 0 | 0 | 247.44M | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 120.55M | 23M | -236.89M | -223.15M | 99.5M | -514.35M | 0 | 0 |
Cash used in financing activities | -507.06M | -257.98M | -263.1M | -385.54M | -20.66M | -616.09M | 999.41M | 300.95M |
Net Change In Cash | 173.31M | -1.70B | 1.09B | 596.02M | 536.23M | 220.57M | -94.94M | 130.13M |
Cash at end of period | 1.13B | 964.2M | 1.91B | 826.64M | 611.28M | 263.11M | 53.85M | 148.80M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |